# Cartesian Therapeutics, Inc. (RNAC) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Cartesian Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RNAC/mda/fy2025/): filed 2026-03-09; accession 0001453687-26-000064 (https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RNAC/mda/fy2024/): filed 2025-03-13; accession 0001453687-25-000060 (https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm)
- [FY 2023 MD&A](/company/RNAC/mda/fy2023/): filed 2024-03-07; accession 0001453687-24-000036 (https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm)
- [FY 2022 MD&A](/company/RNAC/mda/fy2022/): filed 2023-03-02; accession 0001453687-23-000040 (https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm)
- [FY 2021 MD&A](/company/RNAC/mda/fy2021/): filed 2022-03-10; accession 0001453687-22-000051 (https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm)

Back to /company/RNAC/